Mike DeLaroche
EVP Business Development & Integrated Strategy
Expertise:
Mike is helping EVERSANA lead the way in end-to-end, integrated commercialization for the life sciences industry. He leverages more than 30 years of experience across pharma to drive EVERSANA COMPLETE Commercialization, the industry’s only complete commercialization solution. Mike has extensive experience working with emerging and mid-size pharma companies to develop strategy and tactics for successful launches. Throughout his career, he has worked at Johnson & Johnson, Cardinal Health and Syneos Health.
Mike holds an MBA from Pepperdine University and received his bachelor’s degree from San Diego State University.
Articles by Mike DeLaroche
Build the Launch, Then Cut the Deal: A Smarter Playbook for Emerging Biotech Value
For emerging and late-stage biotechs, out-licensing is often viewed as the safer path. Data from our five-year analysis of real-world licensing deal outcomes tells a different story. In this paper, EVERSANA experts break down two critical decisions: Out-license vs. launch independently? If the former, at which stage will out-licensing maximize transactional value? Our experts dive into the key launch and licensing paths that biotechs consider, revealing when commercialization becomes your strongest leverage for long-term value creation. “Data consistently shows that companies launching and […]